Manufacturer
GLAXOSMITHKLINE PHARMACEUTICALS SA
Contents
Dutasteride
Indication
Monotherapy or in combination w/ tamsulosin for treatment & control of symptomatic benign prostatic hyperplasia (BPH) in men w/ enlarged prostate to improve symptoms, reduce the risk of acute urinary retention & the need for BPH-related surgery.
Instruction
May be taken with or without food: Swallow whole, do not chew/open.
Drug interaction
Increased blood conc & decreased clearance w/ CYP3A4 inhibitors eg, verapamil, diltiazem.
Malaysia
